Activity of Anthracyclines in Refractory Ovarian Cancer: Recent Experience and Review

This publication has 25 references indexed in Scilit:

• Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.
  Journal of Clinical Oncology, 1997
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy
  Annals of Oncology, 1993
• Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
  The Lancet, 1992
• Long-term survival in ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1991
• A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study
  Cancer, 1986
• A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma
  Cancer, 1983
• Advanced Ovarian Adenocarcinoma
  New England Journal of Medicine, 1978
• Adriamycin and bleomycin, alone and in combination, in gynecologic cancers
  Cancer, 1973
• CYCLOPHOSPHAMIDE IN THE TREATMENT OF OVARIAN CANCER
  Clinical Obstetrics and Gynecology, 1968